Structure (Metoprolol Succinate Er Drl 1)
Metoprolol Succinate
Product Images NDC 70882-127
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70882-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cambridge Therapeutics Technologies, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Metoprolol Succinate Er Drl 2)
Metoprolol Succinate Er Tablets 25 mg (Metoprolol Succinate Er Drl 3)
The text is a description of a proof for a drug label packaging, containing dosage instructions, warnings, manufacturer and distributor information. The customer is required to proofread and sign the document before it's released into production. The drug, Metoprolol Succinate Extended-Release Tablets, USP, 25mg, is manufactured by Dr. Reddy's Laboratories Limited, and packaged by Legacy Pharmaceutical Packaging, LLC, with CTT Therapeutic Technologies as the distributor. The label also provides instructions on how to unlock the child-resistant feature and store the tablets.*
Metoprolol Succinate Er Tablets 50 mg (Metoprolol Succinate Er Drl 4)
The text contains information on Metoprolol Succinate Extended-Release Tablets USP 50 mg, including the manufacturer information, dosage, and storage instructions. It also includes instructions for opening the child-resistant blister packaging and a warning not to use if the package is broken. The text also mentions a backage insert for full prescribing information, but it is not available in the given text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
